| Added by | mollevi |
|---|---|
| Group name | EquipeJC |
| Item Type | Note |
| Note | Huber, Kilian V M |
| Date Added | 2018/11/14 - 11:48:35 |
| Date Modified | 2018/11/14 - 11:48:35 |
| Parent item | Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy |
Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | mollevi |
|---|---|
| Group name | EquipeJC |
| Item Type | Note |
| Note | Huber, Kilian V M |
| Date Added | 2018/11/14 - 11:48:35 |
| Date Modified | 2018/11/14 - 11:48:35 |
| Parent item | Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de